Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Clinical trial NCT07462260 · RECRUITING

Trial details

NCT number: NCT07462260
Sponsor: Sindh Institute of Cardiovascular Diseases
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Rheumatic Valvular Heart Disease

Start date: 2025-08-01
Primary completion: 2026-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.